FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
MEDICAL AIR, USP
medical air
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
medical air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
medical air
Peak
INHALATION · GAS
2016
NDA30/100
MEDICAL AIR, USP
medical air
Peak
INHALATION · GAS
2015
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
medical air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
medical air
Peak
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
medical air
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
breathing air
Peak
INHALATION · GAS
2014
NDA30/100
MEDICAL AIR, USP
medical air
Peak
United Therapeutics
INHALATION · GAS
2013
NDA30/100
MEDICAL AIR, USP
nitrogen, oxygen
Peak
INHALATION · GAS
2017
NDA30/100
MEDICAL AIR, USP
air compressed
Peak
INHALATION · GAS
2013
NDA30/100
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
meropenem and sodium chloride
Peak
B. Braun
INTRAVENOUS · POWDER
complicated skinskin structure infections (cSSSI) due to Staphylococcus aureus (methicillin-susceptible isolates only)+15
2015
NDA30/100
METHOTREXATE
methotrexate
Peak
Accord Biopharma
INTRAVENOUS · SOLUTION
2020
NDA30/100
MICAFUNGIN
micafungin
Peak
Pfizer
INTRAVENOUS · POWDER
Acute Disseminated CandidiasisAbscesses in adult+1
2021
NDA30/100
MICAFUNGIN
micafungin sodium
Peak
Teva
INTRAVENOUS · POWDER
2021
NDA30/100
MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
midazolam injection, 10 mg
Peak
INTRAMUSCULAR · SOLUTION
status epilepticus in adults
2022
NDA30/100